Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Chief Medical Officer acquired 37,000 shares (grant or award)
  4. 4 Grant or award VP, Finance and CAO acquired 11,000 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 29,000 shares (grant or award)
  6. 4 Grant or award President & CEO acquired 74,000 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Exercise or conversion Chief Financial Officer acquired 15,000 shares (option exercise)
  15. 4 Exercise or conversion President & CEO acquired 24,154 shares (option exercise)
  16. 4 Grant or award VP, Finance and CAO acquired 50,000 shares (grant or award)
  17. 4 Exercise or conversion Chief Medical Officer acquired 23,852 shares (option exercise)
  18. 4 Open-market sale Director sold 325,377 shares at an average $27.36 ($8,901,804)
  19. 4 Open-market sale 10% owner sold 48,390 shares at an average $26.61 ($1,287,431)
  20. 4 Open-market sale Director sold 145,637 shares at an average $32.26 ($4,698,091)

Page 7 of 11 · 213 filings